Your browser doesn't support javascript.
loading
A model of sensitivity and resistance to histone deacetylase inhibitors in diffuse large B cell lymphoma: Role of cyclin-dependent kinase inhibitors.
Tula-Sanchez, Ana A; Havas, Aaron P; Alonge, Peter J; Klein, Mary E; Doctor, Samantha R; Pinkston, William; Glinsmann-Gibson, Betty J; Rimsza, Lisa M; Smith, Catharine L.
Affiliation
  • Tula-Sanchez AA; Department of Pharmacology and Toxicology; College of Pharmacy; University of Arizona; Tucson, AZ USA.
Cancer Biol Ther ; 14(10): 949-61, 2013 Oct 01.
Article in En | MEDLINE | ID: mdl-23982416

Full text: 1 Database: MEDLINE Main subject: Sulfonamides / Lymphoma, Large B-Cell, Diffuse / Cyclin-Dependent Kinase Inhibitor p21 / Cyclin-Dependent Kinase Inhibitor p27 / Histone Deacetylase Inhibitors / Hydroxamic Acids / Antineoplastic Agents Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Cancer Biol Ther Journal subject: NEOPLASIAS / TERAPEUTICA Year: 2013 Type: Article

Full text: 1 Database: MEDLINE Main subject: Sulfonamides / Lymphoma, Large B-Cell, Diffuse / Cyclin-Dependent Kinase Inhibitor p21 / Cyclin-Dependent Kinase Inhibitor p27 / Histone Deacetylase Inhibitors / Hydroxamic Acids / Antineoplastic Agents Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Cancer Biol Ther Journal subject: NEOPLASIAS / TERAPEUTICA Year: 2013 Type: Article